Related Experiment Videos
Diagnosing human parvovirus B19 infection: guidelines for test selection
1University of Pittsburgh, Magee-Women's Research Institute, Pittsburgh, PA 15213, USA. jordanja+@pitt.edu
Molecular Diagnosis : a Journal Devoted to the Understanding of Human Disease Through the Clinical Application of Molecular Biology
|January 5, 2002
Summary
Human parvovirus B19 causes a common childhood illness. Choosing the right diagnostic test, like serology or molecular assays, is crucial for accurate parvovirus B19 diagnosis and patient care.
Area of Science:
- Virology
- Immunology
- Pediatrics
Background:
- Human parvovirus B19 is a common cause of childhood illness with a typically mild course.
- Viral replication targets erythroid precursor cells expressing the globoside receptor.
- Certain populations, including those with shortened red blood cell half-lives, immunocompromised individuals, pregnant women, and fetuses, are at higher risk for severe complications.
Purpose of the Study:
- To emphasize the importance of selecting appropriate diagnostic tests for human parvovirus B19.
- To guide clinicians in choosing between serological testing and molecular amplification assays based on patient status.
Main Methods:
- Review of diagnostic strategies for human parvovirus B19 detection.
- Analysis of patient-dependent factors influencing test selection.
- Comparison of serological assays and molecular amplification assays.
Main Results:
- Serological testing is recommended for immunocompetent individuals with symptoms or exposure history.
- Molecular amplification assays are indicated for patients with inadequate antibody responses.
- Inappropriate test selection can lead to misinformation and misdiagnosis.
Conclusions:
- Clinician education on appropriate parvovirus B19 diagnostic testing is critical.
- Patient-specific factors dictate the choice between serological and molecular tests.
- Accurate diagnosis of parvovirus B19 infection relies on judicious test selection.